The results presented pointed out that EpCAM could serve as a prognostic biomarker for gastrointestinal and head and neck tumors.<h4>Systematic review registration</h4>https://www.crd.york.ac.uk/prospero, identifier CRD42022315070. The gene discussed is EPCAM; the disease is head and neck neoplasm.